# Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder

> **NCT00916552** · PHASE2 · COMPLETED · sponsor: **Lars Vedel Kessing, professor, MD, DMSc.** · enrollment: 83 (actual)

## Conditions studied

- Mood Disorders

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT00916552
- **Lead sponsor:** Lars Vedel Kessing, professor, MD, DMSc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2012-11-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00916552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00916552, "Effects of Erythropoietin on Depressive Symptoms and Neurocognitive Deficits in Depression and Bipolar Disorder". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00916552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*